Analyst Ratings February 24, 2026

Raymond James Lifts Scotiabank Price Target, Citing ROE Upside

Analyst keeps Outperform rating as bank's funding, NIM and fee-growth prospects underpin valuation case

By Nina Shah BNS
Raymond James Lifts Scotiabank Price Target, Citing ROE Upside
BNS

Raymond James increased its 12-month price target on Bank of Nova Scotia to Cdn$117 from Cdn$114 while retaining an Outperform rating, pointing to greater return-on-equity expansion potential driven by funding and NIM improvements, strategic disposals, fee-based revenue growth and disciplined expense control. The bank's latest quarterly results exceeded analysts' expectations on both EPS and revenue, though investors remain attentive to rising credit loss provisions and higher expenses.

Key Points

  • Raymond James raised its price target on Bank of Nova Scotia to Cdn$117 from Cdn$114 and kept an Outperform rating.
  • The firm points to ROE expansion catalysts: funding and NIM improvements, strategic divestitures, fee-based revenue growth and disciplined expense management.
  • Scotiabank beat first-quarter 2026 expectations with EPS of CAD 2.05 (vs CAD 1.96 forecast) and revenue of CAD 10.08 billion (vs CAD 9.7 billion); shares have risen about 58% over the past year and trade near the 52-week high.

Snapshot

Raymond James has raised its price target on Bank of Nova Scotia stock (TSE:BNS) (NYSE:BNS) to Cdn$117.00 from Cdn$114.00 and maintained an Outperform rating.

Analyst rationale

The firm cited Scotiabank’s potential to expand return on equity relative to its peers, a view it ties to a set of execution and structural factors. Those drivers include ongoing improvements in funding and net interest margin (NIM), a program of strategic divestitures, growth in fee-based revenue streams, and disciplined expense management that supports positive operating leverage.

"We continue to view Scotiabank as offering greater ROE expansion potential relative to peers, supported by ongoing funding and NIM improvements, strategic divestitures, growth in fee-based revenue streams, and disciplined expense management supporting positive operating leverage."

Valuation and recent performance

Raymond James notes the stock trades at roughly a 1.5x P/E discount to peers, with a current price-to-earnings ratio of 18.22. Over the past year the shares have returned approximately 58% and trade near their 52-week high. An InvestingPro Fair Value assessment is referenced as indicating Scotiabank appears undervalued, and Raymond James expects the bank can narrow that valuation gap as it executes on its revised strategic plan.

Recent results

Scotiabank’s first-quarter 2026 results beat analyst expectations on both the bottom line and top line. The bank reported adjusted earnings per share of CAD 2.05, above the forecast of CAD 1.96, while revenue came in at CAD 10.08 billion versus an anticipated CAD 9.7 billion. Those outcomes are cited as evidence of the bank’s strong quarter-to-quarter performance.

Investor concerns

Despite the stronger-than-expected earnings and revenue figures, the report notes investor attention remains on rising credit loss provisions and elevated expenses. These items are flagged as points of scrutiny even as the overall results outpace market expectations.

Outlook

Raymond James retains its Outperform rating. The firm’s recommendation and higher target rest on the assumption that the bank will continue to make progress on the listed drivers of ROE expansion, narrowing its valuation gap versus peers as execution unfolds.


The analysis above synthesizes the analyst actions, valuation context and the bank’s reported quarter as presented by the firm and public results.

Risks

  • Rising credit loss provisions could weigh on profitability and affect investor sentiment - impacts banking and credit markets.
  • Increased expenses may constrain margin improvement and limit operating leverage benefits - relevant to bank operating performance and sector profitability.
  • If execution on strategic divestitures and fee-growth initiatives stalls, the anticipated narrowing of the valuation gap versus peers may not materialize - affects equity valuation in the financial sector.

More from Analyst Ratings

TD Cowen Lowers Shoals Technologies Price Target to $10, Cites Margin Pressure During Factory Transition Feb 24, 2026 Jefferies Lifts Home Depot Target, Cites Early-Stage Housing Recovery Feb 24, 2026 Jefferies Sticks With Buy on AMD After Meta GPU Partnership; Analysts Split on Near-Term Upside Feb 24, 2026 Truist Lifts Palvella Therapeutics Price Target After Positive Phase 3 SELVA Results Feb 24, 2026 Truist Lifts Home Depot Price Target After Strong Q4 Performance Feb 24, 2026